The Brink's Company is doing well overall with growth potential. See why BCO stock offers value despite recent guidance cuts ...

The Invesco Bloomberg Analyst Rating Improvers ETF focuses on upgraded stocks. Read why UPGD’s mid-cap emphasis offers a ...

Efti + KEYTRUDA combo shows strong efficacy for NSCLC patients in Immutep's phase 1 study. Read why IMMP stock may see upside ...

GigaCloud Technology's stock dip seems overblown, as the company exceeds Q3 forecasts. Learn why GCT stock is undervalued ...

Medical Properties Trust has made progress with liquidity but faces rising debt and asset write-downs. Learn why MPW stock ...

Digital Turbine (APPS) shares fell around 3% on Friday after BofA downgraded its rating from Neutral to Underperform on the ...

Granite Construction is a top pick for roadwork investments as federal spending boosts infrastructure. Learn why GVA stock is ...

Sensus Healthcare’s strong Q3 performance and new FDA deals suggest growth. Find out why SRTS stock could rise 150% in the ...

Pfizer's drug approvals and advertising revenue could be affected by RFK Jr.'s potential appointment. See why PFE stock is a ...

For the three months ending September 30, 2024, the fund's Retail Class shares gained 10.00%, modestly trailing the 10.59% ...

Short interest as a percentage of total float across S&P 500 real estate stocks decreased to 2.01% as of October 31 from 2.15 ...

The rising dollar and interest rates create a triple threat of lower earnings, growth contraction, and falling P/E ratios.